期刊
INFECTIOUS DISEASES AND THERAPY
卷 10, 期 2, 页码 637-661出版社
SPRINGER LONDON LTD
DOI: 10.1007/s40121-021-00404-y
关键词
Altered immunocompetence; Inactivated vaccines; Live vaccines; Vaccination
Immunisation in patients with altered immunocompetence is challenging due to limited data from vaccine trials, suboptimal vaccine efficacy, and safety concerns. Recommendations for this group are mainly based on expert consensus and may vary geographically, requiring personalized immunization schedules based on local guidelines, age, and type and stage of underlying diseases.
Vaccine-preventable diseases and their related complications are associated with increased morbidity and mortality in patients with altered immunocompetence. Optimised immunisation in this patient population is challenging because of limited data from vaccine trials, suboptimal vaccine efficacy and safety concerns. Reliable efficacy data are lacking among patients with altered immunocompetence, and existing recommendations are mainly based on expert consensus and may vary geographically. Inactivated vaccines can be generally used without risks in this group, but their efficacy may be reduced, and immunisation schedules vary according to local guidelines, age, and type and stage of the underlying disease. Live vaccines, if indicated, should be administered with care because of the risk of vaccine-associated disease. We have reviewed the current evidence on vaccination principles and recommendations in adult patients with secondary immunodeficiencies, including asplenia, HIV infection, stem cell and solid organ transplant, haematological malignancies, inflammatory bowel disease and other chronic disorders.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据